Table S1. Subjects with differentiated thyroid cancer split in subgroups based on thyroid peroxidase antibodies titers. (PDF 32 kb
Table S2. Distribution of thyroid malignancy in patients with and without lymphocytic thyroiditis. (...
Immunostain of CD68 in entire tissue of FTC/FA samples. (A) An example of immunohistochemistry analy...
Supplementary information on the assays tested. Table S1. Specifications of routine assays used. Fig...
Table S2. A) Surface staining using fluorochrome-conjugated antibodies against human. B) Intracellul...
Figure S2. Cytotoxicity of NK cells against K562 cancer target cells. (PDF 404 kb
Figure S1. A) Gating strategies for flow cytometry analysis from representative patients with EHT an...
Appendix 4. Cases of Immune Checkpoint Inhibitors-Induced Endocrinopathies â Thyroid Disorders: (a...
Clinicopathologic characteristics of 223 thyroid cancer patients enrolled in the study. (DOCX 16Â kb
Figure S1. The cumulative incidence of subsequent thyroid disorders in PTE and PTE+ ND groups were p...
Additional file 1: Supplementary Table 1. The associations between TMPRSS4 and distinct immune popul...
Tables S1 and S2. The Table S1 showed the similar observation time in RT and CCRT groups of subjects...
Supplemental data from: Immune Profiling of Thyroid Carcinomas Suggests the Existence of Two Major P...
Figure S7. Distribution of TIS scores in stage IV disease. TIS scores are shown for all TCGA patient...
Table S1. Comparison of clinical characteristics of study patients and remaining N9831 cohort. (DOCX...
Additional file 1: Supplementary Table 1. Detailed information of the selected SNPs between Thyroid ...
Table S2. Distribution of thyroid malignancy in patients with and without lymphocytic thyroiditis. (...
Immunostain of CD68 in entire tissue of FTC/FA samples. (A) An example of immunohistochemistry analy...
Supplementary information on the assays tested. Table S1. Specifications of routine assays used. Fig...
Table S2. A) Surface staining using fluorochrome-conjugated antibodies against human. B) Intracellul...
Figure S2. Cytotoxicity of NK cells against K562 cancer target cells. (PDF 404 kb
Figure S1. A) Gating strategies for flow cytometry analysis from representative patients with EHT an...
Appendix 4. Cases of Immune Checkpoint Inhibitors-Induced Endocrinopathies â Thyroid Disorders: (a...
Clinicopathologic characteristics of 223 thyroid cancer patients enrolled in the study. (DOCX 16Â kb
Figure S1. The cumulative incidence of subsequent thyroid disorders in PTE and PTE+ ND groups were p...
Additional file 1: Supplementary Table 1. The associations between TMPRSS4 and distinct immune popul...
Tables S1 and S2. The Table S1 showed the similar observation time in RT and CCRT groups of subjects...
Supplemental data from: Immune Profiling of Thyroid Carcinomas Suggests the Existence of Two Major P...
Figure S7. Distribution of TIS scores in stage IV disease. TIS scores are shown for all TCGA patient...
Table S1. Comparison of clinical characteristics of study patients and remaining N9831 cohort. (DOCX...
Additional file 1: Supplementary Table 1. Detailed information of the selected SNPs between Thyroid ...
Table S2. Distribution of thyroid malignancy in patients with and without lymphocytic thyroiditis. (...
Immunostain of CD68 in entire tissue of FTC/FA samples. (A) An example of immunohistochemistry analy...
Supplementary information on the assays tested. Table S1. Specifications of routine assays used. Fig...